Evercore ISI Group Maintains In-Line on Zimmer Biomet Holdings, Lowers Price Target to $110
Portfolio Pulse from Benzinga Newsdesk
Evercore ISI Group has maintained an 'In-Line' rating on Zimmer Biomet Holdings (NYSE:ZBH) while lowering the price target from $113 to $110.
October 01, 2024 | 5:07 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Evercore ISI Group has maintained an 'In-Line' rating on Zimmer Biomet Holdings and lowered the price target from $113 to $110, indicating a slightly less optimistic outlook.
The lowering of the price target from $113 to $110 by Evercore ISI Group suggests a slightly less optimistic view on Zimmer Biomet Holdings' future performance, which could lead to a short-term negative impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100